Novo Nordisk A/S Class B (NOVOb)

795.0
+8.7(+1.11%)
  • Volume:
    1,272,602
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    784.7 - 799.4
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0060534915
  • S/N:1742564000

NOVOb Overview

Prev. Close
786.3
Day's Range
784.7-799.4
Revenue
149.03B
Open
799.4
52 wk Range
515.7-834.5
EPS
21.45
Volume
1,272,602
Market Cap
1.8T
Dividend (Yield)
10.40
(1.31%)
Average Volume (3m)
2,022,429
P/E Ratio
37.06
Beta
0.79
1-Year Change
55.58%
Shares Outstanding
2,269,011,119
Next Earnings Date
03 Aug 2022
What is your sentiment on Novo Nordisk B?
or
Market is currently closed. Voting is open during market hours.

Novo Nordisk A/S Class B Analysis

Novo Nordisk A/S Class B Company Profile

Novo Nordisk A/S Class B Company Profile

Employees
49295
Market
Denmark

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy